as on November 7, 2025 at 2:29 am IST
Day's Low
Day's High
4.08%
Downside
7.39%
Upside
52 Week's Low
52 Week's High
31.75%
Downside
45.09%
Upside
Check Zevra Therapeutics Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$565.3M
EPS (TTM)
1.305
Dividend Yield
0.00%
Quarterly Earnings Growth YOY
0.00%
PE Ratio (TTM)
-5.91
Industry PE ratio
0PEG Ratio
10.6667
EBITDA
-53.8M
Revenue (TTM)
62.0M
Profit Margin
4.26%
Return On Equity TTM
3.53%
Track how Zevra Therapeutics Inc P/E has moved over time to understand its valuation trends.
Zevra Therapeutics Inc in the last 5 years
Lowest (-12.38x)
September 30, 2025
Industry (0.00x)
November 7, 2025
Today (-5.91x)
November 7, 2025
Highest (-2.82x)
June 30, 2024
Today’s Price to Earnings Ratio: -5.91x
Compare market cap, revenue, PE, and other key metrics of Zevra Therapeutics Inc with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % |
|---|---|---|---|---|---|
| BUY | $565.3M | NA | -5.91 | 4.26% | |
| BUY | $39.6B | 470.1% | -16.34 | -264.83% | |
| BUY | $57.4B | 236.95% | 1448.53 | 1.36% | |
| BUY | $105.8B | 88.96% | 29.32 | 31.35% | |
| BUY | $67.7B | 11.91% | 15.43 | 32.13% |
The Zevra Therapeutics Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.
Investment Value
₹1,00,000
Zevra Therapeutics Inc investment value today
Current value as on today
₹1,08,058
Returns
₹8,058
(+8.06%)
Returns from Zevra Therapeutics Inc Stock
₹2,951 (+2.95%)
Dollar Returns*
₹5,107 (+5.11%)
Based on 12 analysts
91.67%
Buy
8.33%
Hold
0.00%
Sell
Based on 12 analysts, 91.67% of analysts recommend a 'BUY' rating for Zevra Therapeutics Inc. Average target price of $23.22
Get share price movements and forecasts by analysts on Zevra Therapeutics Inc.
What analysts predicted
60.94%UPSIDE
Target Price
$23.22
Current Price
$9.07
Analyzed by
12 Analysts
Target
$23.22
Zevra Therapeutics Inc target price $23.22, a slight upside of 60.94% compared to current price of $9.07. According to 12 analysts rating.
Search interest for Zevra Therapeutics Inc Stock has increased by 51% in the last 30 days, reflecting an upward trend in search activity.
Time period: to
Change:51% versus previous 30 day period
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Revenue Rich
![]()
Revenue is up for the last 5 quarters, 3.69M → 26.06M (in $), with an average increase of 33.0% per quarter
Against Peers
![]()
In the last 1 year, Insmed Incorporated has given 159.0% return, outperforming this stock by 155.8%
Against Peers
![]()
In the last 3 years, Insmed Incorporated has given 921.9% return, outperforming this stock by 859.3%
Price Dip
![]()
In the last 7 days, ZVRA stock has moved down by -10.7%
Profit Down
![]()
Netprofit is down for the last 2 quarters, 74.70M → -1.41M (in $), with an average decrease of 101.9% per quarter
| Organisation | Zevra Therapeutics Inc |
| Headquarters | 1180 Celebration Boulevard, Celebration, FL, United States, 34747 |
| CEO | Mr. Neil F. McFarlane |
| E-voting on shares | Click here to vote |
Name | Title |
|---|---|
Mr. R. LaDuane Clifton CPA | CFO & Treasurer |
Dr. Adrian Quartel FFPM, M.D. | Chief Medical Officer |
Ms. Nichol L. Ochsner | Vice President of Investor Relations & Corporate Communications |
Dr. Christopher M. Lauderback Ph.D. | Senior Vice President of Manufacturing |
Ms. Tanya Hayden | Senior VP & Chief of Staff |
Mr. Neil F. McFarlane | President, CEO & Director |
Mr. Rahsaan W. Thompson J.D. | Chief Legal Officer, Secretary & Compliance Officer |
Ms. Alison Peters | Chief People Officer |
Mr. Joshua M. Schafer M.B.A. | Chief Commercial Officer |
Mr. Gerald J. Orehostky | Senior Vice President of Regulatory Affairs & Quality |
Zevra Therapeutics Inc share price today is $9.07 as on at the close of the market. Zevra Therapeutics Inc share today touched a day high of $9.74 and a low of $8.7.
Zevra Therapeutics Inc share touched a 52 week high of $13.16 on and a 52 week low of $6.19 on . Zevra Therapeutics Inc stock price today i.e. is closed at $9.07,which is 31.08% down from its 52 week high and 46.53% up from its 52 week low.
Zevra Therapeutics Inc market capitalisation is $0.00T as on .
Indian investors can start investing in Zevra Therapeutics Inc (ZVRA) shares with as little as ₹88.626 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹886.26 in Zevra Therapeutics Inc stock (as per the Rupee-Dollar exchange rate as on ).
Based on Zevra Therapeutics Inc share’s latest price of $9.07 as on November 7, 2025 at 2:29 am IST, you will get 1.1025 shares of Zevra Therapeutics Inc. Learn more about
fractional shares .